Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using <sup>18</sup>F-FDG PET/CT and DW-MRI: A Prospective Multicenter Study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 31987972.
- Also identified by DOI 10.1016/j.ijrobp.2019.12.038 and PMC identifier 7103753.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Accurate preoperative prediction of pathologic response to neoadjuvant chemoradiotherapy (nCRT) in patients with esophageal cancer could enable omission of esophagectomy in patients with a pathologic complete response (pCR). This study aimed to evaluate the individual and combined value of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography with integrated computed tomography (<sup>18</sup>F-FDG PET/CT) and diffusion-weighted magnetic resonance imaging (DW-MRI) during and after nCRT to predict pathologic response in patients with esophageal cancer. In this multicenter prospective study, patients scheduled to receive nCRT followed by esophagectomy for esophageal cancer underwent <sup>18</sup>F-FDG PET/CT and DW-MRI scanning before the start of nCRT, during nCRT, and before esophagectomy. Response to nCRT was based on histopathologic evaluation of the resection specimen. Relative changes in <sup>18</sup>F-FDG PET/CT and DW-MRI parameters were compared between patients with pCR and non-pCR groups. Multivariable ridge regression analyses with bootstrapped c-indices were performed to evaluate the individual and combined value of <sup>18</sup>F-FDG PET/CT and DW-MRI. pCR was found in 26.1% of 69 patients. Relative changes in <sup>18</sup>F-FDG PET/CT parameters after nCRT (Δ standardized uptake value [SUV]<sub>mean,post</sub>P = .016, and Δ total lesion glycolysis <sub>post</sub>P = .024), as well as changes in DW-MRI parameters during nCRT (Δ apparent diffusion coefficient [ADC]<sub>during</sub>P = .008) were significantly different between pCR and non-pCR. A c-statistic of 0.84 was obtained for a model with ΔADC<sub>during</sub>, ΔSUV<sub>mean,post</sub>, and histology in classifying patients as pCR (versus 0.82 for ΔADC<sub>during</sub> and 0.79 for ΔSUV<sub>mean,post</sub> alone). Changes on <sup>18</sup>F-FDG PET/CT after nCRT and early changes on DW-MRI during nCRT can help identify pCR to nCRT in esophageal cancer. Moreover, <sup>18</sup>F-FDG PET/CT and DW-MRI might be of complementary value in the assessment of pCR.
Medical subject headings
- Chemoradiotherapy
- Diffusion Magnetic Resonance Imaging
- Esophageal Neoplasms
- Fluorodeoxyglucose F18
- Neoadjuvant Therapy
- Positron Emission Tomography Computed Tomography